## REQ-p00045: Design Patterns

**Level**: prd | **Status**: Draft | **Implements**: -
**Refines**: REQ-p00044

**Refines**: REQ-p00044-E

**Refines**: p00044-E

## Assertions

A. System components SHALL use common design patterns to ensure consistency

## Rationale

Clinical trial systems must comply with multiple regulatory frameworks depending on geographic scope and data types processed. This requirement establishes the platform's overarching regulatory compliance posture, ensuring that all applicable regulations are systematically addressed through dedicated child requirements. By centralizing regulatory compliance under a single framework requirement, the platform maintains clear traceability from the top-level system definition down to specific regulatory implementations.

*End* *Design Patterns* | **Hash**: a451a0b8
---
## REQ-p00012: Clinical Data Retention Requirements

**Level**: prd | **Status**: Draft | **Implements**: -
**Refines**: REQ-p00048

**Refines**: REQ-p00048

**Refines**: p00048

## Assertions

A. The system SHALL retain clinical trial data for a minimum of 7 years after study completion or product approval when specific regulatory requirements are not defined.

B. The system SHALL provide export capability for regulatory submission.

C. The system SHALL provide export capability for archival purposes.

D. The system SHALL track the retention period per study.

E. The system SHALL enforce the retention period per study.

F. The retention period SHALL be configurable per study.

G. The retention period SHALL be configurable per jurisdiction.

H. Data export SHALL include the complete audit trail.

I. Exported data SHALL be readable without proprietary systems.

J. The system SHALL prevent premature deletion by enforcing retention period requirements.

## Rationale

Regulatory agencies require long-term retention of clinical trial data to support product approvals, post-market surveillance, and potential future investigations. Data must remain accessible and readable despite technology changes over the retention period. FDA 21 CFR Part 11 and ICH GCP guidelines mandate preservation of complete trial records including audit trails for periods typically extending 7+ years after study completion or product approval, depending on jurisdiction.

*End* *Clinical Data Retention Requirements* | **Hash**: 095cb350
---
## REQ-p01085: Compliance Systems

**Level**: prd | **Status**: Draft | **Implements**: -
**Refines**: REQ-p00044-E

**Refines**: REQ-p00044-E

**Refines**: p00045

## Assertions

A. The platform SHALL use libraries for common operations.

*End* *Compliance Systems* | **Hash**: 418d48b6
---
# Clinical Trial Compliance Requirements

**Version**: 1.0
**Audience**: Product Requirements
**Last Updated**: 2026-01-26
**Status**: Draft

> **See**: dev-compliance-practices.md for implementation guidance
> **See**: prd-database.md for data architecture
> **See**: ops-security.md for operational procedures

---

## Executive Summary

Clinical trial systems must comply with strict regulations to ensure data integrity and patient safety. This system is designed to meet all requirements for electronic clinical trial data collection in the United States and European Union.

**Primary Regulations**:

- FDA 21 CFR Part 11 (United States)
- ALCOA+ Data Integrity Principles
- HIPAA (when applicable)
- GDPR (European participants)

---

## Why Compliance Matters

**For Regulators**:

- Ensures clinical trial data is trustworthy
- Protects patients participating in trials
- Maintains integrity of drug approval process

**For Sponsors**:

- Required for regulatory submission
- Reduces risk of study rejection

**For Patients**:

- Defines how to properly handle their data
- Provides privacy protection
- Basis of trust in clinical research

---

## Key Requirements

### System Validation

**What It Means**: The system must be tested and proven to work correctly before use in clinical trials.

**Requirements**:

- Documented test plans and results
- Proof that system does what it claims
- Regular revalidation after changes
- Traceability from requirements to tests

**Benefits**: Provides confidence that the system produces reliable data and won't lose or corrupt patient entries.

---

### Secure Access Control

**What It Means**: Only authorized people can access the system, and each person can only see data they're permitted to view.

**Requirements**:

- Unique user accounts for each person
- Strong password requirements
- Multi-factor authentication for staff
- Automatic logout after inactivity
- Records of all access attempts

**Patient Protection**: Patients can only see their own data. Study staff can only access data at their assigned clinical sites.

---

### Electronic Signatures

**What It Means**: Every action in the system is electronically "signed" by the person performing it.

**Requirements**:

- Records who performed the action
- Records when the action occurred
- Records what the action meant (created, updated, etc.)
- Signature permanently linked to the record

**Implementation**: Automatic - users don't need to explicitly "sign" each action. The system captures their identity with every entry.

---

## Regulatory Submission

When sponsors submit clinical trial data to regulators:

**What Regulators Review**:

- Complete audit trail showing all data changes
- System validation documentation
- Evidence of proper access controls
- Proof that data integrity was maintained

**What This System Provides**:

- Exportable audit logs in standard formats
- Validation documentation package
- Access control reports
- Data integrity verification tools

---

## Data Retention

**Requirements**:

- Clinical trial data must be retained for minimum period (typically 7+ years)
- Audit trails must be retained with the data
- System must ensure data remains accessible and readable

**Compliance**: The system uses standard formats and includes tools for long-term data export and archival.

---

## Privacy Regulations

### HIPAA (United States)

When applicable, the system protects health information:

- Encryption of data at rest and in transit
- Access controls limit who can see data
- Audit logs track all access to patient records
- Patient rights to access their own data

### GDPR (European Union)

For EU participants:

- Data minimization (collect only what's needed)
- Right to access personal data
- Right to data portability
- Right to be forgotten (with clinical trial exceptions)
- Consent management

---

## Compliance Benefits

**Risk Reduction**:

- Lower chance of study rejection by regulators
- Protection against data integrity challenges
- Defense against compliance violations

**Efficiency**:

- Automated compliance reduces manual oversight
- Built-in audit trails eliminate separate documentation
- Faster regulatory review process

**Trust**:

- Patients confident their data is protected
- Sponsors confident in data quality
- Regulators confident in data integrity

---

## Regulatory Reference Documentation

### FDA Requirements Source Documents

The detailed FDA regulatory requirements in `spec/regulations/fda/` are derived from the following authoritative source documents:

| Document | Description | Requirements Mapping |
| --- | --- | --- |
| **21 CFR Part 11** | FDA regulation governing electronic records and electronic signatures | REQ-p80202, REQ-p80302 |
| **FDA Guidance for Industry: Part 11 Scope and Application** | FDA guidance on interpretation and enforcement priorities | REQ-p80203, REQ-p80303, REQ-p80403 |
| **ICH E6(R2) GCP Consolidated Guideline** | International standards for clinical trial conduct | REQ-p80005 |
| **ICH E6(R2) GCP Detailed Requirements** | Specific requirements for electronic systems in clinical trials | REQ-p80204, REQ-p80304, REQ-p80404 |

REQ-p80001 provides the authoritative regulatory source documentation. Platform requirements implement specific FDA domains (p80010-p80060) rather than the umbrella REQ-p00010.

---

## References

- **Implementation Details**: dev-compliance-practices.md
- **Data Architecture**: prd-database.md
- **Security Architecture**: prd-security.md
- **Operations**: ops-security.md
- **FDA Detailed Requirements**: spec/regulations/fda/
- **FDA Guidance**: FDA 21 CFR Part 11
- **ALCOA+ Principles**: Data Integrity and Compliance Guidelines
